244 related articles for article (PubMed ID: 18609264)
1. The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis.
Guler H; Turhanoglu AD; Ozer B; Ozer C; Balci A
Scand J Rheumatol; 2008; 37(5):337-42. PubMed ID: 18609264
[TBL] [Abstract][Full Text] [Related]
2. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up.
Hoff M; Haugeberg G; Odegård S; Syversen S; Landewé R; van der Heijde D; Kvien TK
Ann Rheum Dis; 2009 Mar; 68(3):324-9. PubMed ID: 18339664
[TBL] [Abstract][Full Text] [Related]
3. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
Juhász B; Gulyás K; Horváth Á; Pethő Z; Bhattoa HP; Váncsa A; Szekanecz É; Horváth C; Kocsis J; Horváth Z; Hodosi K; Szántó S; Szűcs G; Szekanecz Z
Osteoporos Int; 2017 Apr; 28(4):1271-1277. PubMed ID: 27942777
[TBL] [Abstract][Full Text] [Related]
4. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
[TBL] [Abstract][Full Text] [Related]
5. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.
Tan YK; Li H; Allen JC; Thumboo J
Int J Rheum Dis; 2020 Oct; 23(10):1337-1343. PubMed ID: 33460311
[TBL] [Abstract][Full Text] [Related]
6. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Greisen SR; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Hvid M; Deleuran B
Scand J Rheumatol; 2014; 43(2):101-8. PubMed ID: 24182347
[TBL] [Abstract][Full Text] [Related]
7. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
8. Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis.
Wysham KD; Shoback DM; Imboden JB; Katz PP
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):961-969. PubMed ID: 29106028
[TBL] [Abstract][Full Text] [Related]
9. Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.
Hamad MB; Marzouk S; Kaddour N; Masmoudi H; Fakhfakh F; Rebai A; Bahloul Z; Maalej A
J Clin Lab Anal; 2014 Jan; 28(1):21-6. PubMed ID: 24375820
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P
J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between wrist bone mineral density and synovitis, erosion by ultrasonography in female rheumatoid arthritis patients].
Wang Y; Geng Y; Deng XR; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):774-80. PubMed ID: 26474614
[TBL] [Abstract][Full Text] [Related]
12. Trabecular bone density in premenopausal rheumatoid arthritis patients.
Kalla AA; Bewerunge L; Langley A; Meyers OL; Fataar AB
S Afr Med J; 2002 Jan; 92(1):62-8. PubMed ID: 11936021
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
15. Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.
Ziegelasch M; Forslind K; Skogh T; Riklund K; Kastbom A; Berglin E
Arthritis Res Ther; 2017 Sep; 19(1):195. PubMed ID: 28865482
[TBL] [Abstract][Full Text] [Related]
16. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
[TBL] [Abstract][Full Text] [Related]
17. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
[TBL] [Abstract][Full Text] [Related]
18. Anti-CCP antibody levels are not associated with MS: results from a case-control study.
Alpayci M; Milanlioglu A; Delen V; Aydin MN; Guducuoglu H; Bayram Y
Biomed Res Int; 2015; 2015():817427. PubMed ID: 25722987
[TBL] [Abstract][Full Text] [Related]
19. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
